Kerala Medical Services Corporation not procured rabies jabs without CDL certificate: Nadda
He was responding to a question whether the manufacturers supplying anti-rabies vaccine to KMSCL had done the mandatory tests from the CDL during the last five years and the current year.
"As informed by Kerala Medical Services Corporation , all Rabies Vaccines and Equine Anti-Rabies Immunoglobulins procured and distributed by them from the tender year 2016-17 onwards have obtained Batch Release Certificates from Central Drugs Laboratory , Kasauli, as mandated in the tender terms and conditions," Nadda said.
"KMSCL has not procured or distributed any batch of Rabies vaccine or Equine Anti-rabies Immunoglobulin without a batch release certificate from CDL," Nadda said.
For the manufacturing or import of new drugs, including vaccines, the manufacturers and importers are required to comply with the standards of quality, safety and efficacy as prescribed in the Drugs and Cosmetics Act, 1940 and Rules.
The mandatory quality requirements prescribed to ensure the quality of anti-rabies vaccines being manufactured in the country include a manufacturing licence and import licence issued under the Drugs and Cosmetics Act and Rules and that the anti-rabies vaccine must comply with the standards specified in the current edition of the Indian Pharmacopoeia.
Each batch must undergo complete in-house quality control testing at the manufacturer's facility according to validated procedures and IP standards.
Each batch or lot of vaccines manufactured or imported in the country is required to be released by the CDL at Kasauli in Himachal Pradesh before the release of vaccines for sale and distribution, Nadda explained.
He said that proper cold chain logistics, two degrees Celsius to eight degrees Celsius must be maintained throughout storage and transportation to preserve vaccine potency and vaccines must have a valid remaining shelf life at the time of supply and should be packaged to ensure protection during transit and storage.
According to Rule 2 of New Drugs and Clinical Trial Rules, 2019, vaccines are always deemed to be new drugs.
All manufacturers of vaccines have to comply with the conditions of mandatory quality tests apart from other conditions of licence as prescribed under Rules 78 and 78A of Drug Rules, 1945 and both the Central License Approving Authority and state licensing authorities are empowered to take stringent action against violation of provisions of the Act and Rules.
This article was generated from an automated news agency feed without modifications to text.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
8 minutes ago
- Hindustan Times
Ludhiana: Parents oppose state's bond policy for MBBS students, write to Centre
Parents of medical aspirants have presented a petition to the Union minister for health and family welfare JP Nadda against the Punjab health department's policy of submitting a two years and one year bond period for MBBS students. Dr Deepak Jangra, along with other parents has written to the Union health minister and asked the National Medical Commission (NMC) to restrain the compulsory bond. The parents said that the restrictions and financial pressure imposed by such bonds create a punitive environment that detracts students from the overall educational experience. (HT photo for representation) In a circular issued on June 13 June, the state health department had enunciated a bond of two years for students from the state quota and a bond of one year for all India quota for admissions to the new batch of MBBS. 'In 2024 the National Task Force (NTF) formed by the NMC had recommended that such bonds in practice across the country should be revised. They had said that these were brought back when there was shortage of doctors due to less number of medical colleges. But now the situation has changed and the policy needs to be revised.' said Dr Jangra. The letter to the Union minister quotes the NTF reports as saying, 'Both the compulsory rural service bond and seat leaving bonds should be reconsidered and removed at the earliest.' Dr Jangra claimed that doing MBBS at a government college in Punjab costs around ₹10 lakh compared to ₹1.5 lakh in Chandigarh or elsewhere. 'If the students have to pay so much more than the government institutes elsewhere, then why shouldn't they be allowed the freedom to pursue their careers as they wish instead of being forced to work in government hospitals for two years,' he asked. The parents said that the restrictions and financial pressure imposed by such bonds create a punitive environment that detracts students from the overall educational experience. States, they claim instead of investing in institutes to produce more health resources tried to compensate with such bonds. Dr Jangra said that the state should invest in public health infrastructure to solve the problems instead of putting strain on students with bonds. 'Punjab already has a bond policy for doctors who pursue PG on government quota. This is for the first time that the policy has been extended to MBBS students,' he added. However, Punjab health minister Dr Balbir Singh didn't respond to multiple calls when approached for a comment. Parents of the students who are to join the MBBS course this year and those preparing for NEET UG for next two years have also challenged the policy in the Punjab and Haryana high court.
Time of India
5 hours ago
- Time of India
Gujarat ranks 3rd in sickle cell disease
Ahmedabad: Data tabled in the Lok Sabha on Aug 1 indicated that Gujarat, with 28,178 identified sickle cell disease patients, has the third-largest patient base in the country. Odisha, with 96,484 cases, leads the table, and is followed by Madhya Pradesh with 30,762 cases, according to data shared by Union health minister J P Nadda in response to a question by Rajkumar Raot. What set Gujarat apart was that 90% of the cases (25,282) were recorded among the scheduled tribes (ST), including those in the particularly vulnerable tribal group (PVTG) category, which was the highest among Indian states and significantly higher compared to Odisha and Madhya Pradesh, according to the statistics up to the end of July 2025. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad The answer indicated that a total of 77.34 lakh citizens were screened to identify those with the condition. Under the National Sickle Cell Anaemia Elimination Mission (NSCAEM), persons with the condition are provided counselling regarding lifestyle, pre-marriage and pre-natal decisions and nutritional supplements among others. "The condition is marked by abnormal haemoglobin that makes red blood cells rigid and take the shape of a sickle. They often block the blood flow, leading to anaemia," a public health expert said. "Gujarat has recently launched a drive to understand the genetic makeup of the tribal population," the expert added.
Indian Express
7 hours ago
- Indian Express
Gujarat to prepare SOPs to stop duplicate, fake medicines from entering state
The Gujarat government, in a statement on Tuesday, said it is in the process of formulating Standard Operating Procedures (SOPs) to enhance detection and seizures of duplicate and fake medicines from entering the state. 'Recently, it came to the notice of the state government that fake medicines are entering (Gujarat). They are being sourced from outside the state and sold in some places inside the state. Gujarat's Food and Drug Control Administration (FDCA) has also taken action by conducting on-site inspections. To make this more stringent and strict, the government will prepare an SOP for the inspection of medicines coming from outside the state into Gujarat,' Health Minister Rushikesh Patel was quoted as saying. The SOPs would make registration of imported medicines mandatory, require registration of transporters carrying medicines and cancellation of licenses of chemists or wholesalers who are caught in such dealing with fake medicines. The SOPs will also require people to strictly follow the Drugs and Cosmetics Act. Besides, expensive and 'fast-moving' medicines will be closely monitored. The state government will also start three new testing labs in addition to the existing NABL-certified laboratory in Vadodara. To intensify on-site testing, 10 sets of state-of-the-art hand-held devices (Raman Spectrometer with Advanced Technology) will be purchased. Further, a flying squad will be formed. Patel added that with the implementation of these SOPs, Gujarat will become the first state in the country to adopt 'zero-tolerance' towards duplicate and fake medicines. 'The government will take intensive action to prevent fake/spurious/counterfeit medicines from outside the state in Gujarat. In the last 4 years, raids were conducted to prevent counterfeit medicines/cosmetics in the state and more than Rs 6 crore (worth of) medicines/cosmetics were seized…about 75 persons/firms were found involved and action was taken against them,' a statement read. Speaking about the type of activities unearthed so far, the statement said, 'In most of these cases, persons who do not have a valid license for buying, selling and storing medicines are involved and investigation has also revealed that in most of the cases, counterfeit medicines come from outside the state.'
